XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional paid-in capital
Warrants
Retained earnings (Accumulated deficit)
Retained earnings (Accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2018     42,104,000          
Beginning balance at Dec. 31, 2018 $ 419,271 $ (51) $ 421 $ 508,655   $ (58,491) $ (51) $ (31,314)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]                
Net income (32,656)         (32,656)    
Dividends declared or accrued for common stock (8,907)     (8,907)        
Shares issues for option exercises (in shares)     5,000          
Shares issued for option exercises (21)     (21)        
Share-based compensation expense (in shares)     231,000          
Share-based compensation expense 3,130   $ 2 3,128        
Restricted shares forgiven for taxes (in shares)     (43,000)          
Restricted shares forgiven for taxes (151)     (151)        
Change in estimate of share-based award vesting (1,240)     (1,240)        
Change in fair value of interest rate swap, net of tax (11,999)             (11,999)
Reclassification of interest rate swap settlement to net income (loss), net of tax 238             238
Foreign currency translation gain (loss) (11,354)             (11,354)
Ending balance (in shares) at Sep. 30, 2019     42,297,000          
Ending balance at Sep. 30, 2019 356,302   $ 423 501,506   (91,198)   (54,429)
Beginning balance (in shares) at Jun. 30, 2019     42,367,000          
Beginning balance at Jun. 30, 2019 377,329   $ 424 504,556   (85,343)   (42,308)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]                
Net income (5,855)         (5,855)    
Dividends declared or accrued for common stock (2,973)     (2,973)        
Shares issues for option exercises (in shares)     5,000          
Shares issued for option exercises (21)     (21)        
Share-based compensation expense (in shares)     (50,000)          
Share-based compensation expense 1,151   $ (1) 1,152        
Restricted shares forgiven for taxes (in shares)     (25,000)          
Restricted shares forgiven for taxes (10)     (10)        
Change in estimate of share-based award vesting (1,240)     (1,240)        
Change in fair value of interest rate swap, net of tax (1,181)             (1,181)
Reclassification of interest rate swap settlement to net income (loss), net of tax 238             238
Foreign currency translation gain (loss) (11,178)             (11,178)
Ending balance (in shares) at Sep. 30, 2019     42,297,000          
Ending balance at Sep. 30, 2019 356,302   $ 423 501,506   (91,198)   (54,429)
Beginning balance (in shares) at Dec. 31, 2019     42,313,000          
Beginning balance at Dec. 31, 2019 353,277   $ 423 501,615 $ 1,076 (105,283)   (44,554)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]                
Net income (247,969)         (247,969)    
Dividends accrued for preferred stock (9,133)     (9,133)        
Share-based compensation expense (in shares)     442,000          
Share-based compensation expense 4,142   $ 4 4,138        
Restricted shares forgiven for taxes (in shares)     (16,000)          
Restricted shares forgiven for taxes (76)     (76)        
Reclassification of warrants to liabilities (Note 18) (1,076)       (1,076)      
Change in estimate of share-based award vesting (577)     (577)        
Change in fair value of interest rate swap, net of tax (12,443)             (12,443)
Reclassification of interest rate swap settlement to net income (loss), net of tax 6,838             6,838
Foreign currency translation gain (loss) (6,636)             (6,636)
Ending balance (in shares) at Sep. 30, 2020     42,739,000          
Ending balance at Sep. 30, 2020 86,347   $ 427 495,967 0 (353,252)   (56,795)
Beginning balance (in shares) at Jun. 30, 2020     42,747,000          
Beginning balance at Jun. 30, 2020 57,899   $ 427 498,294 1,076 (375,222)   (66,676)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]                
Net income 21,970         21,970    
Dividends accrued for preferred stock (3,139)     (3,139)        
Share-based compensation expense 1,435     1,435        
Restricted shares forgiven for taxes (in shares)     (8,000)          
Restricted shares forgiven for taxes (46)     (46)        
Reclassification of warrants to liabilities (Note 18) (1,076)       (1,076)      
Change in estimate of share-based award vesting (577)     (577)        
Change in fair value of interest rate swap, net of tax 21             21
Reclassification of interest rate swap settlement to net income (loss), net of tax 3,148             3,148
Foreign currency translation gain (loss) 6,712             6,712
Ending balance (in shares) at Sep. 30, 2020     42,739,000          
Ending balance at Sep. 30, 2020 $ 86,347   $ 427 $ 495,967 $ 0 $ (353,252)   $ (56,795)